跳至主要内容
临床试验/CTRI/2015/12/006438
CTRI/2015/12/006438已完成2 期

Evaluation of anti-oxidant and anti-inflammatory activity ofCurcuma longa extract in osteoarthritis subjects: A pharmacological approach.

Himalaya Drug Company0 个研究点目标入组 160 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Primary osteoarthritis of knee

排除标准

  • Subject having RA and secondary arthritis.
  • Subjects more than 80 years and less than 40 years.
  • Subjects having metabolic disorder such as diabetes, hepatitis, cardiovascular disease.
  • Subject having malignant disease.
  • Subject having other genetic disorder.
  • Subject having respiratory disease.
  • Subject having HIV disease.

研究者

发起方
Himalaya Drug Company

相似试验